Abstract:Eight new jatrophane diterpenoids, Euphosorophane F-M (1-8), as well as fourteen known jatrophane diterpenoids (9-22) were separated and purified from the fructus of Euphorbia sororia, and the chemical structures were determined based on extensive spectroscopic analysis, 1D, 2D NMR and HRESIMS data included. Their absolute configurations of compounds 1, 2, 9, and 22 were elucidated by X-ray crystallographic analysis. These jatrophane diterpenoids showed lower cytotoxicity and compounds 3, 4, 11, 12, 13, 14, and 20 revealed promising multidrug resistance (MDR) reversal ability as modulators compared to verapamil (VRP) by MTT assay. The structure-activity relationship (SAR) exhibited that the absence of keto-carbonyl at C-9 and C-14 was essential to MDR reversal activity and the acyloxies substitution at C-5, C-7, C-8, and C-14 also made the activity difference. Euphosorophane I (4) particularly unfold greater potency (EC50 = 1.82 μM) in reversing P-gp-mediated resistance to doxorubicin (DOX). As shown by fluorescence microscopy, 4 promoted intracellular accumulation of rhodamine 123 (Rh123) and DOX in a dose-dependentmanner than VRP. Flow cytometry indicated that 4 inhibitedP-glycoprotein (P-gp) -dependentRh123 efflux in drug-resistant MCF-7/ADR cells. 4 stimulated P-gp-ATPase activity in a concentration-dependent way and inhibited DOX transport activity. Western blot and real-time qPCR results further illustrated that 4 exhibited superior MDR reversal effect in MCF-7/ADR cells attributed to the activation of ATPase rather than the upregulation of P-gp expression and mRNA levels. In addition, 4 bond to the drug-binding site of P-gp predicted by the molecular docking analysis. Collectively, these results indicated that 4 efficiently reversed P-gp-mediated MDR via inhibiting the ABCB1 drug efflux function. 4 with the advantage of low toxicity and efficient could be used as an adjuvanttherapy drug for breast cancer.

Lathyrane Diterpenes from Euphorbia Lathyris As Modulators of Multidrug Resistance and Their Crystal Structures.

Euphohyrisnoids A and B, Two Highly Rearranged Lathyrane Diterpenoids from Euphorbia Lathyris

Four lathyrane diterpenoids from the seeds of Euphorbia lathyris

Enhancing lathyrane structural diversity and MDR activity by combinatorial modification of lathyrane nucleus and ester side chain: A case study of Euphorbia Factor L1 and Euphorbia Factor L3

Lathyrane diterpenoids with multidrug resistance reversal activity from the tubers of Euphorbia antiquorum

Synthesis, antiproliferative and anti-MDR activities of lathyrane diterpene derivatives based on configuration inversion strategy

Targeted discovery of unusual diterpenoids with anti-fungal activity from the root of Euphorbia lathyris

Diterpenoids from the Seeds of <i>Euphorbia lathyris</i> and their Cytotoxic Acitivity

Diterpenoids from the seeds of Euphorbia lathyris and their anti-inflammatory activity

Mechanism of action of cytotoxic compounds from the seeds of Euphorbia lathyris

Regioselective Hydroxylation of Lathyrane Diterpenoids Biocatalyzed by Microorganisms and Its Application in Integrated Synthesis

Jatrophane diterpenoids as multidrug resistance modulators from Euphorbia sororia

Structural Elucidation of Three 9,11-Seco Tetracyclic Triterpenoids Enables the Structural Revision of Euphorol J

Lathyrane and ent -isopimarane diterpenoids from Euphorbia wallichii and target prediction of active ingredient

Jatrophane Diterpenoids from Euphorbia Peplus As Multidrug Resistance Modulators with Inhibitory Effects on the ATR-Chk-1 Pathway.

Lathyrane Diterpenoids As Novel Hpxr Agonists: Isolation, Structural Modification, and Structure-Activity Relationships

Jatrofolianes A and B: Two Highly Modified Lathyrane Diterpenoids from Jatropha Gossypiifolia.

Diterpenoids from the seeds of Euphorbia lathyris and their effects on microglial nitric oxide production

Structurally diverse triterpenoids with cytotoxicity from Euphorbia hypericifolia

Lathyrane diterpenoids from Euphorbia lathyris induce cell-cycle arrest and apoptosis in human hypertrophic scar cells

Jatrophane Diterpenoids as Modulators of P-Glycoprotein-Dependent Multidrug Resistance (MDR): Advances of Structure-Activity Relationships and Discovery of Promising MDR Reversal Agents.